Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178853 | SCV000231018 | benign | not specified | 2015-02-05 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000178853 | SCV000257904 | benign | not specified | 2015-02-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000178853 | SCV000308421 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000834559 | SCV000976329 | benign | not provided | 2018-06-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000834559 | SCV001730816 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002276557 | SCV002566439 | benign | Connective tissue disorder | 2022-07-18 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000018677 | SCV000038960 | risk factor | Intervertebral disc disease, susceptibility to | 2001-04-11 | no assertion criteria provided | literature only | |
Genome Diagnostics Laboratory, |
RCV000178853 | SCV002035238 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000178853 | SCV002037652 | benign | not specified | no assertion criteria provided | clinical testing |